Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06033261 |
|---|---|
| Brief Title: | A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes |
| First Submitted : | September 5, 2023 |
| First Submitted that Met QC Criteria : | September 5, 2023 |
| First Posted : | September 13, 2023 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 3, 2024 |